Autoimmunity in the brain: The pathogenesis insight from cell biology

Annals of the New York Academy of Sciences

Volumn 1107, Issue , 2007, Pages 142-154

  Jovanova Nesic, Katica ^a   Shoenfeld, Yehuda ^b,c  

^a Immunology Research Center Belgrade   (Yugoslavia)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmune brain inflammation; Inflammatory demyelination; Neuroimmune interactions

Indexed keywords

CHEMOKINE; CYTOKINE; MYELIN; PEPTIDE HYDROLASE;

ANIMAL CELL; ANIMAL TISSUE; ASTROCYTE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLOGY; DEMYELINATING DISEASE; DEMYELINATION; ENDOTHELIUM CELL; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GLIA CELL; IMMUNOCOMPETENT CELL; MACROPHAGE; MICROGLIA; MONOCYTE; NONHUMAN; PATHOGENESIS; RAT; RAT STRAIN; T LYMPHOCYTE; ANIMAL; ARTICLE; ENZYMOLOGY; HUMAN; IMMUNOLOGY; METABOLISM; OLIGODENDROGLIA; VIRULENCE;

ANIMALS; ASTROCYTES; AUTOIMMUNITY; BRAIN; DEMYELINATING AUTOIMMUNE DISEASES, CNS; HUMANS; OLIGODENDROGLIA; PEPTIDE HYDROLASES; VIRULENCE;

EID: 34648814431     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1381.016     Document Type: Conference Paper

References (88)

1. JANKOVIC, B.D. & D. KUSIC. 1989. Autoimmune futures of Parkinson's disease. In Neuroimmune Networks: Physiology and Disease. E.J. Goetzl & N.H. Spector, Eds.: 259-267. Alan R. Liss., Inc. New York.
2. JOVANOVA-NESIC, K., V. NIKOLIC & B.D. JANKOVIC. 1993. Locus ceruleus and immunity II: suppression of experimental allergic encephalomyelitis and hypersensitivity skin reactions in rats with lesioned locus ceruleus. Int. J. Neurosci. 68: 289-294.
3. STANIC, S., K. HLADNI & K. JOVANOVA- NESIC. 1995. Lesioned substantia nigra affects humoral and cellular immune response and motor performance in the open field behavior. Eur. J. Neurosci. 7:(Suppl.) 181.
4. POPOVIC, M., K. JOVANOVA-NESIC, N. POPOVIC, et al. 1997. Humoral and cell-mediated immune responses following lesions of the nucleus basalis magnocellularis in the rat. Int. J. Neurosci. 89: 165-176.
5. HOTARY, E., E. ALLEN, A. PUNTURIERI, et al. 2000. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 149: 1309-1323.
6. TEESALU, T., A.E. HINKKANEN & V. ANTTI. 2001. Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. Am. J. Pathol. 159: 2227-2237.
7. ANDO, D.G., J. CLAYTON, D. KONDO, et al. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol. 124: 132-143.
8. WEKERLE, H., K.L. LANNES-VIEIRA, H. LASSMANN, et al. 1994. Animal models (review). Ann. Neurol. 36: S47-S48.
9. BROSSNAN, C.F. & C.S. RAINE. 1996. Mechanisms of injury in multiple sclerosis. Brain Pathol. 6: 243-252.
10. RAJAN, A.J., Y.-L. GAO, C.S. RAINE, et al. 1996. A pathogenic role for γδ T cells in relapsing-remitting experimental allergic encephalomyelitis. J. Neuroimmunol. 157: 941-953.
11. FREEDMAN, M.S., T.C. RUIJS, L.K. SELIN, et al. 1991. Peripheral blood γβ T cells lyses fresh human brain-derived oligodendrocytes. Ann. Neurol. 30: 794.
12. HVAS, J., J.R. OKSENBERG, R. FERNANDO, et al. 1993. γβ T cell receptor repertoire in brain lesions of patients with multiple sclerosis. J. Neuroimmunol. 46: 225-230.
13. FERRICK, D.A., M.D. SCHRENZEL, T. MUBIANTIA, et al. 1995. Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γβ T cells in vivo. Nature 373: 255-263.
14. LOCK, C., G. HERMANS, R. PEDOTTI, et al. 2002. Gene microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8: 500-508.
15. BECHER, B., I. BECHMANN & M. GETER. 2006. Antigen presentation in autoimmunity and CNS inflammation: low T lymphocytes recognize the brain. J. Mol. Med. 84: 532-543.
16. DAVIES, G. & G. KEIR. 2003. The clinical significance of an intrathecal monoclonal immunoglobulin bund; a follow-up study. Neurology 60: 1163-1166.
17. SHOENFELD, Y., A. NAHUM, A.D. KOREZYN, et al. 2003. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12: 436-442.
18. CARONI, B., C. CALDERARO, C. ALESSANDRI, et al. 1998. Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J. Autoimmun. 11: 425-429.
19. YOSHIO, T., J. MASUYAMA & S. KANO. 1996. Antiribosomal P0 protein antibodies react with the surface of human umbilical vein endothelial cells. J. Rheumathol. 23: 1311-1322.
20. KOWAL, C., L.A. DEGIORGIO, T. NAKAOKO, et al. 2004. Cognition and immunity: antibody impairs memory. Immunity 21: 179-188.
21. STORCH, M.K. & H. LASSMANN. 1997. Pathology and pathogenesis of demyelinating diseases. Curr. Opin. Neurol. 10: 186-192.
22. PIDDLESDEN, S.J., H. LASSMANN, H. WEKERLE, et al. 1993. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143: 555-564.
23. BIRKEDAL-HANSEN, H. 1995. Proteolytic remodeling of extracellular matrix. Curr. Top Dev. Biol. 24: 219-257.
24. TSIRKA, S.E., A.D. ROGOVE & S. STRICKLAND. 1996. Tissue plasminogen activator and neuronal cell death. Nature 384: 123-124.
25. JONES, J.L. & R.A. WALKER. 1997. Control of matrix metalloproteinase activity in cancer. J. Pathol. 183: 377-379.
26. AGENSTECHER, A., A.K. STABLER, C.L. KINCIAD, et al. 1998. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory state. Am. J. Pathol. 152: 729-733.
27. WERB, Z., C.L. MAINARDI, C.A. VATER, et al. 1977. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N. Engl. J. Med. 296: 1017-1023.
28. BARAMOVA, E.N., K. BAJOU, A.L. REMAKLE, et al. 1997. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in second step of pro-MMP-2 activation. FEBS Lett. 405: 157-162.
29. CUZNER, M.L., D. GVERIC, H. STRAND, et al. 1996. The expression of tissue type plasminogen activator, matrixmetalloproteinases and endogenous inhibitor in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 55: 1194-1204.
30. GIJBELS, K., S.H. MASURE, H. CARTON, et al. 1992. Gelatinase in the cerebral fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J. Neuroimmunol. 41: 29-34.
31. KWAAN, H.C. 1992. The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev. 11: 291-311.
32. ANDREASEN, P.A., L. KJOLLER, L. CHRISTENSEN, et al. 1997. The urokinase-type plasminogen activator in cancer metastasis: a review. Int. J. Cancer 72: 1-22.
33. PATTERSON, P.Y., C.-S. KOH & H.C. KWAAN. 1987. Role of the clotting system in the pathogenesis of neuroimmunologic disease. Fed. Proc. 46: 91-96.
34. TOFT-HANSEN, H., R.K. NUTTAL, D.R. EDWARDS, et al. 2004. Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J. Immunol. 173: 5209-5218.
35. BROWN, A., D.E. MCFARLIN & C.S. RAINE. 1982. Cholinergic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab. Invest. 46: 171-185.
36. OTTERSEN, O.P. & J. STORM-MATHISEN. 1992. Neurons containing or accumulating transmitter amino acids. In Handbook of Chemical Neuroanatomy. A. Bjorkund, T. Hokfelt & M.J. Kuhar, Eds.: 157-161. Elsevier. Amsterdam.
37. CHOI, D.V. 1988. Glutamate neurotoxicity and diseases of nervous system. Neuron 1: 623-634.
38. TAKAHASHI, H., C. KOEHLER, S.W. BRUSILOV, et al. 1991. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. J. Am. Physiol. Soc. 261: 825-829.
39. SMITH, M.E. & M.A. SOMMER. 1992. Association between cell-mediated demyelination and astrocyte stimulation. Prog. Brain Res. 94: 411-422.
40. HARDIN-POUZET, H. & M. KRAKOWSKI. 1998. Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis. Glia 20: 79-85.
41. MORGANTI-KOSSMANN, M.C., T. KOSSMANN & S.M. WAHL. 1992. Cytokines and neuropathology. Trends Neurosci. 13: 186-191.
42. SCHOUSBOE, A., N. WESTERGAARD & L. HERTZ. 1993. Neuronal-astrocytic interactions in glutamate metabolism. Biochem. Soc. Trans. 21: 49-53.
43. MCGEER, L.P. & J.C. ECCLES & E.G. MCGEER. 1978. Signaling in the nervous system: ionic mechanism of the nerve impulse. In Molecular Neurobiology of the Mammalian Brain. P.L. McGeer, J.C. Eccles & E.G. McGeer, Eds.: 41-45. Plenum Press. New York & London.
44. PELES, E. & M. NATIV. 1997. Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. EMBO J. 16: 978-988.
45. CHARLES, P., S. TAIT, C. FAIVRE-S ARAILH, et al. 2002. Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axonal junction. Curr. Biol. 12: 217-220.
46. HICKEY, W.F., B.L. HSU & H. KIMURA. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28: 254-261.
47. ENGELHARDT, J.I., J. TAJTI & S.H. APPEL. 1993. Lymphocyte infiltrates in the spinal cord in amyotropic lateral sclerosis. Arch. Neurol. 50: 30-36.
48. BARON, J., J.A. MARDI, G. RUDDLE, et al. 1993. Surface expression of α4integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177: 57-63.
49. KUCHROO, V., C. MARTIN, J. GREER, et al. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151: 4371-4377.
50. GRAESSER, D., S. MAHOOTI, T. HAAS, et al. 1993. The relationship of α4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis. Lab. Invest. 78: 1445-1454.
51. HOFMANN, N., N. LACHNIT, M. STREPPEL, et al. 2002. Increased expression of ICAM-1, VCAM-1, MCP-1, and MIP-1α by spinal perivascular macrophages during experimental allergic encephalomyelitis in rat. BMC Immunol. 3: 11-30.
52. GLABINSKI, A.R., V.K. TOUHY & R.M. RANSOHOFF. 1998. Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation 5: 166-171.
53. BRADI, J., A. BAUER, H. FLUGEL, et al. 2005. Complementary contribution of CD4 and CD8 T lymphocytes to T-cell infiltration of the intact and degenerative spinal cord. Am. J. Pathol. 166: 1441-1450.
54. HERSHKOVIZ, R., F. MORE, D. GILAT, et al. 1992. T cells in the spinal cord in experimental autoimmune encephalomyelitis are matrix adherent and secrete tumor necrosis factor alpha. J. Neuroimmunol. 37: 161-166.
55. SVENSSON, L. K. B., J. ABDUL-MAJID, H. BAUER, et al. 2002. A comparative analysis of B-cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B-cell-deficient mice reveals an efficient on demyelination. Eur. J. Immunol. 32: 1939-1951.
56. PRINEAS, J.V. & J.C. GAHAM. 1981. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann. Neurol. 10: 149-150.
57. GAY, D. & M. ESIRI. 1999. Blood-brain barrier damage in acute multiple sclerosis plaques: an immunocytochemical study [Abstract]. Brain 114: 557.
58. LASSMANN, H. 1997. Basic mechanisms of brain inflammation. J. Neural. Transm. 50(Suppl.): 183-190.
59. ENGELHARDT, B., F.K. CONLEY & E.C. BUTCHER. 1994. Cell-adhesion molecules on vessels during inflammation in the mouse central nervous system. J. Neuroimmunol. 61: 199-208.
60. MARTIN, M. & K. RESCH. 1988. Interleukin-1: more than a mediator between leukocytes. Trends Neurosci. 9: 171-177.
61. CROFT, M. & C. DUBDAY. 1997. Accessory molecule and costimulation requirements for CD4 T cell response. Crit. Rev. Immunol. 17: 89-118.
62. SUN, D. & H. WEKERLE. 1986. Ia restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature 320: 89-118.
63. MATSUMOTO, Y., J. OHMORI & M. FUJIHARA. 1992. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T-cells under in vivo mimicking conditions. Immunology 76: 209-216.
64. JOVANOVA-NESIC, K. & Y. SHOENFELD. 2006. MMP-2, VCAM-1 and NCAM-1 expression in the brain of rats with experimental autoimmune encephalomyelitis as a trigger mechanism for synaptic plasticity and pathology. J. Neuroimmunol. 181: 112-121.
65. GRAEBER, M.M., W.J. STREIT, W.J. KIEFER, et al. 1990. New expression of myelomonocyte antigens by microglia and perivascular cells following lethal motor neuron injury. J. Neuroimmunol. 27: 121-132.
66. BAUER, J., T. SMINIA, F.G. WOUTERLOOD, et al. 1994. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J. Neurosci. Res. 38: 365-375.
67. TRAPP, B.D., J. PETERSON, R.M. RANSOHOFF, et al. 1998. Axonal transaction in the lesions of multiple sclerosis. N. Engl. J. Med. 338: 278-285.
68. KIEFER, R., B.C. KIESEIER, G. STOLL, et al. 2001. The role of macrophages in the immune-mediated damage to the peripheral nervous system. Prog. Neurobiol. 64: 109-127.
69. KAWAKAMI, N., U.V. NAGER, F. ODOARDI, et al. 2005. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesions. J. Exp. Med. 201: 1805-1814.
70. RAINE, C.S., B. CANNELLA, A.M. DUIJVESTIN, et al. 1990. Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab. Invest. 63: 476-489.
71. HICKEY, W.F. & H. KIMURA. 1988. Perivascular microglial cells of the CNS are bone marrow derived and present antigen in vivo. Science 239: 290-292.
72. GRAEBER, M.B., W.J. STREIT & G.W. KREURZBERG. 1989. Identity of ED2-positive perivascular cells in rat brain. J. Neurosci. Res. 22: 103-106.
73. MORI, S. & C.P. LEBLOND. 1969. Identification of microglia in light and electron microscopy. J. Comp. Neurol. 135: 57-80.
74. MATO, N., S. OOKARE, A. SAKAMOTO, et al. 1996. Involvement of specific macrophage-lineage cell surrounding arterioles in barrier and scavenger function in brain cortex. Proc. Natl. Acad. Sci. 93: 3269-3274.
75. GRAEBER, M.B., W.J. STREIT, R. KIFFER, et al. 1992. Ultrastructural location of major histocompatibility complex (MHC) class II positive perivascular cells in histologically normal human brain. J. Neuropathol. 22: 303-311.
76. KIDA, S., P.V. STREIT, E.T. ZHANG, et al. 1993. Perivascular cells act as scavenger in rat cerebral perivascular spaces and remain distinct from pericytes, microglia and macrophages. Acta Neuropathol. 85: 646-652.
77. BECHMANN, I., E. KWITZINSKI, A.D. KOVAC, et al. 2001. Turnover of rat brain perivascular cells. Exp. Neurol. 168: 242-249.
78. DIJKSTRA, C.D. & J.G.M.C. DAMOISEAUX. 1993. Macrophage heterogeneity established by immunocytochemistry. Prog. Histochem. 27: 1-65.
79. WELLER, R.O., B. ENGELHARDT & M.J. PHYLLIPS. 1996. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol. 6: 275-288.
80. GIULIAN, D. 1987. Ameboid microglia as effectors of inflammation in the central nervous system. J. Neurosci. Res. 18: 155-171.
81. KILLACKEY, H.P. 1984. Glia and the elimination of transient cortical projections. Trends Neurosci. 7: 225-226.
82. RIO-HORTEGA, P. 1932. Microglia. In Cytology and Cellular Pathology of the Nervous System. W. Penfield, Ed.: Vol. 2, 481-584. Paul B. Hoeber, Inc. New York.
83. OEHNICHEN, M. 1983. Inflammatory cells in the central nervous system. Prog. Neuropathol. 5: 277-335.
84. OKA, A., M.J. BELIVEAU, P.A. ROSENBERG, et al. 1993. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J. Neurosci. 13: 1441-1453.
85. NOWAK, L., P. BREGESTOVSKI, P. ACHER, et al. 1984. Magnesium gates glutamate-activated channels in mouse central neurons. Nature 307: 462-465.
86. FRANSDEN, A. & A. SCHOUSBOE. 1994. Effect of magnesium on NMDA mediated toxicity and increases in Ca2+ and cGMP in cultured neocortical neurons: evidence for distinct regulation of different responses. Neurochem. Int. 25: 301-302.
87. WERENER, P., D. PITT & C.S. RAINE. 2001. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann. Neurol. 50: 169-180.
88. COMPSTON, A., N. SCOLDING & M. NOBLE. 1991. The pathogenesis of demyelinating disease: insights from cell biology. Trends Neurosci. 14: 175-182.